Ah what? You just told me " IMU released 2 excellent clinical trial updates in the last 12 months with the latest only a few months ago for Azer-Cel " so which is it, they did or didnt?
If they did release excellent results and they were discounted as you said , why is it different this time? Why is it low risk? I would say its higher risk if good clinical trials didnt even get the share price up. What happens when its bad?
Always the anthem of hotcopper holders when their stock is down "its the big boys" or different iterations like "its the big boys trying to take your shares" "tree shake" "bots at work" "traders manipulating the stock" with absoutely no knowledge of the mechanics behind it, cant just admit that share price is what it is and in this case its legitimate volume exiting the stock.
No one to blame but ourselves when we get caught in a stock, we hit the buy at the time, not big boys , its our fault for blindly trusting management, the story they spin , not looking at macro signals and volume, etc. Take some responsisbility.
IMU Price at posting:
3.6¢ Sentiment: Hold Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)